Fagron Compounding Partners API Compatibility Overview

Oral GLP-1 is changing the packaging conversation. Recent UK reports about oral Wegovy access are more than a weight-management drug headline. They point to a broader shift in the GLP-1 supply chain: from injection devices only, to oral solid-dose packaging as part of the stability strategy. For injectable GLP-1 products, the industry focuses on pens, cartridges, dose accuracy and patient operation. For oral GLP-1 and peptide-related tablets, the questions become different: How should the tablet be protected from moisture? Can the container closure system support shelf life? What happens after repeated opening by the patient? Is a desiccant cap or moisture-proof bottle needed? How should packaging support regulatory review and real-world use? This is why moisture-proof pharmaceutical packaging deserves more attention in the oral peptide market. HDPE desiccant bottles, silica gel cap systems, CRC moisture-proof bottles and induction-seal compatible packaging may become important options for oral GLP-1 tablets, peptide tablets and other humidity-sensitive solid dosage forms. The GLP-1 opportunity is no longer only about drug delivery devices. It is becoming a broader packaging strategy. #GLP1 #PharmaceuticalPackaging #DrugDelivery #OralGLP1 #PeptideDrugs #MoistureProofPackaging #DesiccantBottle #PharmaPackaging #OralSolidDose #PackagingInnovation

What's Inside a Tablet Matters More Than You Think. When we think about medicines, we often focus on the active ingredient—the component responsible for treating a condition. However, a high-quality pharmaceutical product is the result of both active and inactive ingredients working together. Active Ingredients: • Produce the intended therapeutic effect • Target the medical condition • Deliver accurate dosage and efficacy • Are rigorously tested for safety Inactive Ingredients: • Provide the tablet with structure and consistency • Improve stability and shelf life • Enhance coating, taste, and patient experience • Ensure proper dissolution and drug release Each ingredient plays a critical role in delivering medicines that are safe, effective, and reliable. At Oxpro Pharma, we believe excellence starts with quality at every stage of formulation. 🌐Learn more about products: https://lnkd.in/g-BHfB6C Let’s connect on WhatsApp: https://bit.ly/4dHGzHb #OxproPharma #PharmaceuticalManufacturing #HealthcareInnovation #PharmaIndustry #QualityAssurance #MedicineManufacturing #Healthcare #LifeSciences #PatientSafety #Innovation

Retest Date ≠ Expiry Date. Yet many professionals still use them interchangeably. Understanding the difference is essential for maintaining GMP compliance, ensuring product quality, and making the right inventory decisions. Here’s a quick breakdown: ✔ Retest Date: Applies to APIs, raw materials, and excipients. Materials may be re-tested and used if they continue to meet specifications. ✔ Expiry Date: Applies to finished pharmaceutical products. After this date, the product should not be distributed or used. Knowing when to re-test and when a product has truly expired helps protect patient safety, reduce compliance risks, and support efficient inventory management. Which topic would you like us to cover next? #pharma #gmp #qualityassurance #api #pharmaceuticalmanufacturing

Pharmaceutical product shelf life ? The shelf life of a pharmaceutical product is the period during which it is expected to remain within its approved quality specifications (such as potency, purity, safety, and performance) when stored under the recommended conditions. Point covers: It is determined through stability studies conducted according to international guidelines (such as International Council for Harmonisation ( ICH) of Technical Requirements for Pharmaceuticals for Human Use guidelines). Shelf life is expressed as the expiration date or expiry date on the product label. During its shelf life, the product should be maintained: 1.Required strength (potency) 2.Chemical, physical, and microbiological stability 3.Safety and efficacy Shelf life depends on factors such as: 1.Drug formulation 2.Packaging material 3.Storage conditions (temperature, humidity, light) Type of dosage form (tablet, injection, suspension, etc.) Example: If a medicine is manufactured in January 2026 and has a 24-month shelf life, its expiry date would typically be December 2027 or January 2028, depending on the manufacturer's dating convention and local regulatory requirements. #pharmaknowledge. #pharmagyaan

🧴 Why Proper Hand Sanitization Matters Hand sanitization is one of the most effective ways to minimize microbial contamination, prevent the spread of microorganisms, and maintain GMP compliance in pharmaceutical manufacturing. In aseptic and cleanroom environments, when hands are not visibly soiled, sanitization with 70% IPA (Isopropyl Alcohol) is recommended. The complete hand sanitization procedure takes 20–30 seconds. 📌 Step-by-Step Hand Sanitization Procedure Step 1: Apply a sufficient quantity of 70% IPA to cover all hand surfaces. Step 2: Rub palms together (palm to palm). Step 3: Rub the right palm over the back of the left hand with fingers interlaced, then repeat with the opposite hand. Step 4: Rub palm to palm with fingers interlaced to clean between the fingers. Step 5: Rub the backs of fingers against the opposite palms with fingers interlocked. Step 6: Clean each thumb using rotational rubbing in the opposite palm. Step 7: Clean fingertips and nails by rotational rubbing in the opposite palm. Step 8: Continue rubbing until the 70% IPA has completely evaporated and your hands are dry. Do not wipe or rinse your hands. ✅ Key Takeaway Proper hand sanitization with 70% IPA, when performed using the correct technique and contact time, helps minimize microbial contamination, supports GMP compliance, and ensures product quality and patient safety in pharmaceutical manufacturing. #Pharmaceutical #AsepticManufacturing #70IPA #HandSanitization #GMP #ContaminationControl #Cleanroom #QualityAssurance #PatientSafety #PharmaManufacturing

📢 Pharma Packaging Academy #07 5 Questions to Ask Before Choosing a Pharmaceutical Packaging Supplier Selecting a pharmaceutical packaging supplier is about more than comparing prices. A reliable supplier should help ensure consistent quality, stable supply, and long-term cooperation. Before making a decision, here are five important questions worth asking. ✅ 1. Does the supplier have experience in pharmaceutical packaging? Working with an experienced supplier helps reduce risks and ensures a better understanding of pharmaceutical industry requirements. ✅ 2. Can the supplier provide complete technical documentation? Ask for documents such as COA, TDS, product specifications, and relevant certifications to support your evaluation process. ✅ 3. Is product quality consistent from batch to batch? Consistency is essential for smooth production and reliable blister packaging performance. ✅ 4. Can the supplier support your production schedule? Stable lead times and reliable delivery are just as important as product quality. ✅ 5. Does the supplier provide technical support? A professional supplier should be able to answer technical questions and assist when packaging challenges arise. 💡 Industry Insight A long-term partnership is built on quality, consistency, communication, and trust—not only on price. At JerelPack, we are committed to supplying reliable pharmaceutical blister packaging materials, including Alu Alu Foil, Blister Aluminum Foil (PTP), and PVC/PVDC Film, with consistent quality and responsive technical support. 💬 Question for Engagement When selecting a pharmaceutical packaging supplier, what is your highest priority—quality, delivery, technical support, or price? #PharmaceuticalPackaging #PackagingSupplier #BlisterPackaging #AluAluFoil #PTPFoil #PVCFilm #PVDCFilm #PharmaceuticalManufacturing #SupplyChain #JerelPack

SS316 and SS304 ball valves — the standard choice for pharmaceutical, food processing, and clean utility applications where contamination control is critical. Full bore and reduced bore, threaded and flanged ends. https://lnkd.in/gnxvG2ne #SS316Valve #StainlessSteel #PharmaValve #FoodIndustry

What if aseptic filling could be simpler, safer, and more efficient? Rommelag's Blow-Fill-Seal (BFS) technology forms, fills, and hermetically seals containers in one fully automated aseptic process—helping pharmaceutical manufacturers reduce contamination risk, improve productivity, lower operating costs, and meet stringent regulatory requirements. Suitable for applications ranging from ophthalmics and inhalation therapies to injectables and large-volume parenterals, BFS delivers the efficiency and reliability modern pharmaceutical production demands. #Rommelag #BFS #AsepticFilling #PharmaceuticalManufacturing

What if aseptic filling could be simpler, safer, and more efficient—all in one process? With our Aseptic Filling Machines, Blow-Fill-Seal (BFS) technology forms the container, fills it with the sterile product, and hermetically seals it in one fully automated step. Why pharmaceutical manufacturers choose BFS: ✔ Minimized contamination risk through a closed aseptic process with no human intervention ✔ High productivity with outputs of up to 37,500 containers per hour ✔ Compact machine design requiring significantly less cleanroom space ✔ Fast format changes to increase manufacturing flexibility ✔ Lower operating costs through reduced energy consumption and lean production ✔ Designed to comply with today's regulatory requirements, including EU GMP Annex 1 From ophthalmics and inhalation therapies to injectables and large-volume parenterals, Rommelag offers aseptic filling solutions for a wide range of pharmaceutical applications. Because aseptic manufacturing isn't just about filling a container—it's about protecting every patient who relies on it. #Rommelag #BFS #AsepticFilling #PharmaceuticalManufacturing #Annex1

Ready to expand your trichology compounding formulary? Our TrichoLine™ offers vehicle systems built to pair with Minoxidil, Finasteride, Dutasteride, and other trichology-relevant APIs. Highlights from our BUD validation program: - 180-day BUDs supported for select TrichoFoam™ & TrichoSol™ formulations - 31 preparations tested for stability and Antimicrobial Effectiveness (USP <51>), in alignment with updated USP <795> requirements - Excipient profiles free of parabens, propylene glycol, mineral oil/petrolatum, and more For use by licensed compounding professionals only. This material is a bulk pharmaceutical ingredient/vehicle and is not an FDA-approved finished drug product. Not for retail sale. Compounded preparations utilizing this material require a valid patient-specific prescription and must be prepared by a licensed pharmacist in compliance with applicable federal and state laws, including Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act. Visit Fagron Academy to learn more: https://lnkd.in/gCWN8fut To purchase APIs or bases from Fagron, visit: https://lnkd.in/guqs-t4y #CompoundingPharmacy #FagronAcademy #TrichoCompounding #USP795 #CompoundingScience